Delivery Order SPE2DB20D7066-SPE2DB25FC4TS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,743.68 to AmerisourceBergen Drug Corp for Mycophenolate 200 mg/ml suspension in 160 ml quantities. The contract, awarded July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award falls under a competitive procurement process, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical supply requirements. The...
- The Defense Logistics Agency awarded a delivery order valued at $3,022.37 to AmerisourceBergen Drug Corp for the supply of Mycophenolate 200 mg/mL suspension (160 mL) on September 18, 2025, with completion targeted for September 19, 2025. This is a firm fixed price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $4,296.65 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mycophenolate 200 mg/ml suspension in a 160 ml quantity, with completion targeted for July 28, 2025. This firm fixed price contract represents a non-competitive set-aside award to the pharmaceutical distributor's corporate office, with performance to be executed in Conshohocken, Pennsylvania, where the company maintains its headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mycophenolate 500 mg vials, with a ceiling value of $1,066.56. This non-competitive delivery order was executed on September 22, 2025, with an ultimate completion date of September 23, 2025, utilizing firm fixed price pricing. The pharmaceutical product will be delivered to the contracting location in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. This...
- On September 29, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,673.03 to AmerisourceBergen Drug Corp for the supply of Mycophenolate 250 mg capsules (500 count). This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents a continuation of AmerisourceBergen's substantial role as a pharmaceutical supplier to the Department of Defense medical procurement system. The award was made on a competitive,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,576.30 in Mycophenolate 500 mg tablets (500-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This is a firm fixed-price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,284.84 to AmerisourceBergen Drug Corp for the supply of Mycophenolate 250 mg capsules (500 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a $1,219.46 delivery order to AmerisourceBergen Drug Corp for Mycophenolate 500 mg tablets (100 count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price, competitively awarded contract—which includes no set-aside designation—represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Mycophenolate 500 mg tablets (500 count) valued at $1,676.36. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency has awarded a delivery order valued at $2,990.28 to AmerisourceBergen Drug Corp for 100 tablets of Mycophenolate 500 mg, with an ultimate completion date of April 23, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively on April 22, 2025. The pharmaceutical product will be delivered to Conshohocken, PA, where AmerisourceBergen Drug Corp maintains its corporate office and primary operations. This delivery order is issued...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4TSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Mycophenolate 200 mg/mL suspension in 160 mL quantities, with a contract ceiling value of $1,326.21. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on September 16, 2025, and will be performed at the vendor's Conshohocken, Pennsylvania location. The award carries no set-aside designation, indicating the contract was competed among all eligible vendors. This delivery order represents a task order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp leverages this comprehensive global pharmaceutical support vehicle to supply a broad range of medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current delivery order for Mycophenolate, an immunosuppressant medication, exemplifies the company's role in supporting military healthcare programs with specialized pharmaceutical products across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/15/25 |